Page 34 - Pharma Services News Today

NeoGenomics (NASDAQ:NEO – Get Rating) had its target price cut by research analysts at BTIG Research from $35.00 to $28.00 in a report released on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. BTIG Research’s target price would suggest a potential upside of 57.39% from the company’s […]

03/24/22 Pharmaceutical Online Newsletter

Rising consumer preference for sustainable packaging and changing government guidelines of several nations are expected to bolster the clinical trial...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation.

The "Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Outlook 2020-2030" report has been added to ResearchAndMarkets.com's offering. The market is estimated

Almac Pharma Services Expands its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal ProductsTailored service enables processing and QP release within 20 hoursAlmac Pharma Services, a member of the Almac Group providing innovative pharmaceutical development, manufacture and commercial services, ha...

Two Sigma Advisers LP acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 7,000 shares of the medical research company’s stock, valued at approximately $338,000. Other hedge funds have also recently bought and sold […]

Tailored service enables processing and QP release within 20 hours...

Tailored service enables processing and QP release within 20 hoursCRAIGAVON, Northern Ireland, March 14, 2022, a member of the Almac Group providing innovative pharmaceutical development, manufacture and